# Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients

> **NCT04372355** · PHASE2 · COMPLETED · sponsor: **Srinakharinwirot University** · enrollment: 40 (actual)

## Conditions studied

- Diabetic Foot Ulcer (DFU)
- Uncontrolled Diabetes With Foot Ulcer

## Interventions

- **DRUG:** WF10

## Key facts

- **NCT ID:** NCT04372355
- **Lead sponsor:** Srinakharinwirot University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-19
- **Primary completion:** 2020-04-30
- **Final completion:** 2020-06-19
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04372355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04372355, "Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04372355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*